Collegium Pharmaceutical (COLL) Gross Margin Growth (3y) (2019 - 2026)
Collegium Pharmaceutical (COLL) Gross Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 567.00 |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -100.00 |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | -196.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -228.00 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 12.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | -61.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Collegium Pharmaceutical | 887.48 Mn | 738.16 Mn | 110.29 Mn | 71.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 79,985.00 |
| Mar 31, 2026 | 712.00 |
| Dec 31, 2025 | 2,709.00 |
| Sep 30, 2025 | 1,537.00 |
| Jun 30, 2025 | 1,527.00 |
| Mar 31, 2025 | -315.00 |
| Dec 31, 2024 | 26,742.00 |
| Sep 30, 2024 | 227.00 |
| Jun 30, 2024 | 193.00 |
| Mar 31, 2024 | -27.00 |
| Dec 31, 2023 | 512.00 |
| Sep 30, 2023 | -212.00 |
| Jun 30, 2023 | -749.00 |
| Mar 31, 2023 | 251.00 |
| Dec 31, 2022 | 155.00 |
| Sep 30, 2022 | 1,042.00 |
| Jun 30, 2022 | 722.00 |
| Mar 31, 2022 | 2,388.00 |
| Dec 31, 2021 | -6,299.00 |
| Sep 30, 2021 | 2,405.00 |